Galcanezumab-Gnlm 00002-2377-00
- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- September 27, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Galcanezumab | 120 mg/mL |
Selected Package
00002-2377-00Selected1 mL in 1 SYRINGE (0002-2377-00)